Citicoline and Piracetam Tablets | CITICOTIME PM 400

Description

Neurological and cognitive disorders such as memory loss, poor concentration, stroke-related complications, and age-related cognitive decline are becoming increasingly common. Early and effective neuro-support plays a vital role in improving brain function and quality of life. CITICOTIME PM 400, a combination of Citicoline 500 mg and Piracetam 400 mg tablets, is formulated to support brain health, enhance cognitive performance, and promote neurological recovery. Citicoline and Piracetam are well-known nootropic agents that work synergistically to improve cerebral metabolism, enhance neurotransmitter activity, and protect brain cells from damage. CITICOTIME PM 400 is widely prescribed by healthcare professionals for patients with neurological disorders, cognitive impairment, and post-stroke recovery. Uses of Citicoline 500 mg and Piracetam 400 mg Tablets CITICOTIME PM 400 is used in the management of various neurological and cognitive conditions, including: Memory loss and reduced cognitive function Stroke and post-stroke rehabilitation Vascular dementia and age-related cognitive decline Head injury and traumatic brain injury Learning and concentration difficulties Alzheimer’s disease and other neurodegenerative disorders Brain ischemia and cerebral insufficiency This combination therapy helps improve brain efficiency and supports faster neurological recovery. Benefits of CITICOTIME PM 400 Enhances Memory and Cognitive Function Citicoline supports the synthesis of phospholipids in brain cell membranes, helping improve memory, learning ability, and mental clarity. Piracetam enhances communication between brain hemispheres, leading to better cognitive performance. Supports Stroke Recovery CITICOTIME PM 400 improves cerebral blood flow and oxygen utilization, which helps reduce brain damage after ischemic stroke and supports faster functional recovery. Neuroprotective Action Both Citicoline and Piracetam protect neurons from oxidative stress and damage caused by reduced blood supply or injury, helping preserve brain structure and function. Improves Focus and Alertness Regular use may help improve attention span, mental alertness, and concentration, especially in patients with cognitive decline or brain fatigue. Helps in Age-Related Brain Disorders This combination is beneficial for elderly patients experiencing memory issues, confusion, or reduced mental sharpness due to aging or vascular conditions. Dosage The dosage of CITICOTIME PM 400 should always be taken as prescribed by a healthcare professional. Usually taken once or twice daily Can be taken with or after food to reduce gastric discomfort Swallow the tablet whole with water Dosage and duration depend on the patient’s age, medical condition, and response to treatment. Do not alter the dose without medical advice. Side Effects CITICOTIME PM 400 is generally well-tolerated when used as directed. However, some patients may experience mild side effects, such as: Headache Dizziness Nausea or stomach discomfort Insomnia or restlessness Anxiety or irritability These side effects are usually temporary and subside as the body adjusts to the medication. If symptoms persist or worsen, consult a doctor promptly. Precautions and Warning Use with caution in patients with kidney disorders Not recommended during pregnancy and breastfeeding unless prescribed Avoid alcohol consumption during treatment Inform your doctor if you have a history of epilepsy or seizures Do not drive or operate heavy machinery if dizziness occurs Keep out of reach of children Always inform your physician about other medicines you are taking to avoid potential drug interactions. Conclusion CITICOTIME PM 400, containing Citicoline 500 mg and Piracetam 400 mg tablets, is a reliable and effective neuro-supportive therapy designed to improve cognitive function, protect brain cells, and enhance recovery in neurological disorders. Its dual-action formulation addresses both brain metabolism and neurotransmission, making it a valuable option in stroke rehabilitation, memory disorders, and age-related cognitive decline.